The content on this site is intended for healthcare professionals only
Dr Bishal Gyawali discusses with ecancer an article from BMJ about the revolving door between the FDA and the pharmaceutical industry.
He elaborates on the potential conflicts of interest arising when an FDA employee leaves their position to immediately join the pharmaceutical industry.
Dr Gyawali further emphasises the possible bias that could emerge from an FDA regulator whose ambition is to eventually work in the pharma industry, and he suggests measures to prevent such conflicts.
https://www.bmj.com/content/386/bmj.q1418
New classification for identifying HR myeloma based on cytogenetic abnormalities
The case for global gender-neutral HPV vaccination
Boosting HPV vaccination in India: A call to action
Legislation – a powerful tool for promoting massive changes
Gaza's cancer patients: Navigating the dual struggle of illness and war
Tackling breast cancer screening in conservative communities
Cooperative training for medical staff in Côte d'Ivoire: The national radiotherapy and medical oncology center project
Post-diagnosis diet, nutrition and cancer prognosis
WCI's role in the prevention of tobacco related cancer among Beedi rolling women in India
